BeOne Medicines Ltd.
ONC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651308
In the last 90 days, BeOne Medicines Ltd. insiders filed 0 open-market purchases and 16 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $9.93B in total; no superinvestor holds it.
Other share classesBEIGF
Q2 2021 vs. Q1 2021
How the institutions holding BeOne Medicines Ltd. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 253 | 2 | 268 | +17 |
| Shares | 56.8M | 238.7K | 55.8M | −780.7K (−1.4%) |
| Value | $19.5B | $83.1M | $19.1B | −$371.4M (−1.9%) |
2 institutions that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (34)
Institutions that held BeOne Medicines Ltd. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (17)
Institutions that held BeOne Medicines Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Hudson Bay Capital Management LP | 15,000 | $5.22M |
| Hennion & Walsh Asset Management, Inc. | 6,721 | $2.34M |
| Banco de Sabadell, S.A | 3,081 | $1.03M |
| Sands Capital Management, LLC | 1,875 | $653.0K |
| Athanor Capital, LP | 1,715 | $597.0K |
| Seven Eight Capital, LP | 2,100 | $543.0K |
| DuPont Capital Management Corp | 1,442 | $502.0K |
| Phoenix Holdings Ltd. | 696 | $232.0K |
| Greenleaf Trust | 599 | $209.0K |
| Steward Partners Investment Advisory, LLC | 400 | $139.2K |
| Eudaimonia Partners, LLC | 19 | $7.00K |
| Federation des caisses Desjardins du Quebec | 17 | $5.90K |
| International Assets Investment Management, LLC | 17 | $4.00K |
| Spire Wealth Management | 12 | $4.00K |
| Northwestern Mutual Wealth Management Co | 9 | $3.00K |
| Stuart Chaussee & Associates, Inc. | 3 | $1.00K |
| Meridian Wealth Partners, LLC | 4 | $1.00K |
Not filed for Q2 2021 yet (2)
Institutions that held BeOne Medicines Ltd. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Waddell & Reed Financial Inc | 141,119 | $49.1M |
| Amundi Asset Management US, Inc. | 97,572 | $34.0M |